ANI Pharma Nabs $25M Teva Generic Drug Portfolio
Minnesota-based ANI Pharmaceuticals Inc. announced Monday that is has scooped up 22 generic drugs from Teva Pharmaceutical Industries Ltd. for a total purchase price of $25 million....To view the full article, register now.
Already a subscriber? Click here to view full article